GRP78 Is Expressed on the Cell Surface of Pediatric AML Blasts and Can be Targeted with GRP78-CAR T Cells without Toxicity to Hematopoietic Progenitor Cells
Nikhil Hebbar(University of Kentucky), Mireya Paulina Velasquez(St. Jude Children's Research Hospital), Sujuan Huang(St. Jude Children's Research Hospital), Stephen Gottschalk(St. Jude Children's Research Hospital), Cheng Cheng(Jilin University), Abishek Vaidya(Icahn School of Medicine at Mount Sinai), Rebecca Epperly(St. Jude Children's Research Hospital)
Cited by 2
Related Papers
The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)
|The Lancet|2017|856
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
|JNCI Journal of the National Cancer Institute|2009|530
Anterior Hypopituitarism in Adult Survivors of Childhood Cancers Treated With Cranial Radiotherapy: A Report From the St Jude Lifetime Cohort Study
|Journal of Clinical Oncology|2015|280
<i>TP53</i> Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children
|Journal of Clinical Oncology|2018|179
New Frontiers in Osteoporosis Therapy
|Annual Review of Medicine|2019|141